ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 132 filers reported holding ANTARES PHARMA INC in Q1 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $410,000 | +14.8% | 100,000 | 0.0% | 0.00% | – |
Q4 2021 | $357,000 | -1.9% | 100,000 | 0.0% | 0.00% | – |
Q3 2021 | $364,000 | -16.5% | 100,000 | 0.0% | 0.00% | – |
Q2 2021 | $436,000 | +6.1% | 100,000 | 0.0% | 0.00% | – |
Q1 2021 | $411,000 | +3.0% | 100,000 | 0.0% | 0.00% | – |
Q4 2020 | $399,000 | +47.8% | 100,000 | 0.0% | 0.00% | – |
Q3 2020 | $270,000 | -1.8% | 100,000 | 0.0% | 0.00% | – |
Q2 2020 | $275,000 | +16.5% | 100,000 | 0.0% | 0.00% | – |
Q1 2020 | $236,000 | -49.9% | 100,000 | -0.3% | 0.00% | – |
Q4 2019 | $471,000 | +10.6% | 100,262 | -21.1% | 0.00% | – |
Q3 2019 | $426,000 | -12.9% | 127,086 | -14.5% | 0.00% | – |
Q2 2019 | $489,000 | +1.7% | 148,656 | -6.3% | 0.00% | – |
Q1 2019 | $481,000 | -20.4% | 158,594 | -28.6% | 0.00% | -100.0% |
Q4 2018 | $604,000 | +79.8% | 222,039 | +122.0% | 0.00% | – |
Q3 2018 | $336,000 | +30.2% | 100,000 | 0.0% | 0.00% | – |
Q2 2018 | $258,000 | +17.3% | 100,000 | 0.0% | 0.00% | – |
Q1 2018 | $220,000 | +10.6% | 100,000 | 0.0% | 0.00% | – |
Q4 2017 | $199,000 | -38.6% | 100,000 | 0.0% | 0.00% | – |
Q3 2017 | $324,000 | +0.6% | 100,000 | 0.0% | 0.00% | – |
Q2 2017 | $322,000 | +13.4% | 100,000 | 0.0% | 0.00% | – |
Q1 2017 | $284,000 | +21.9% | 100,000 | 0.0% | 0.00% | – |
Q4 2016 | $233,000 | +23200.0% | 100,000 | +14714.8% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 675 | -3.8% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 702 | +3.5% | 0.00% | – |
Q4 2015 | $1,000 | -80.0% | 678 | -74.7% | 0.00% | – |
Q3 2015 | $5,000 | 0.0% | 2,678 | +0.9% | 0.00% | – |
Q2 2015 | $5,000 | -28.6% | 2,655 | +11.7% | 0.00% | – |
Q1 2015 | $7,000 | 0.0% | 2,376 | 0.0% | 0.00% | – |
Q4 2014 | $7,000 | 0.0% | 2,376 | -29.6% | 0.00% | – |
Q3 2014 | $7,000 | -87.5% | 3,376 | -83.6% | 0.00% | – |
Q2 2014 | $56,000 | -23.3% | 20,576 | 0.0% | 0.00% | – |
Q1 2014 | $73,000 | -42.1% | 20,576 | -27.0% | 0.00% | – |
Q4 2013 | $126,000 | +18.9% | 28,200 | +7.6% | 0.00% | – |
Q3 2013 | $106,000 | +71.0% | 26,200 | +74.7% | 0.00% | – |
Q2 2013 | $62,000 | – | 15,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |